Furunculosis

Infectious Disease MONDO:0100595 Pathograph 9 Bacterial Infection Skin and soft tissue infection

Furunculosis is a recurrent deep follicular infection with localized abscess (boil) formation, usually caused by Staphylococcus aureus. The condition is closely linked to persistent colonization reservoirs and virulence factors, including Panton-Valentine leukocidin (PVL), that promote recurrence and severe suppurative disease.

0
Mappings
0
Definitions
0
Inheritance
8
Pathophysiology
0
Histopathology
2
Phenotypes
9
Pathograph
0
Genes
2
Treatments
0
Subtypes
2
Differentials
0
Datasets
3
Trials
0
Models
1
Literature
⚙

Pathophysiology

8
Colonization reservoir and follicular inoculation
Persistent S. aureus colonization of asymptomatic reservoirs predisposes to recurrent follicular inoculation and deep suppurative infection.
keratinocyte link neutrophil link
innate immune response link neutrophil activation link
hair follicle link hypodermis link
Show evidence (2 references)
PMID:38518792 SUPPORT Human Clinical
"Because S aureus infections commonly arise from asymptomatic colonisation, decolonisation is considered a key approach for their prevention."
Supports asymptomatic colonization as the upstream reservoir for infection episodes.
PMID:22803835 SUPPORT Human Clinical
"Nasal carriage of S. aureus is the primary risk factor for recurrent furunculosis and occurs in 60% of individuals."
Supports reservoir colonization as a central mechanism in recurrence.
PVL-associated neutrophilic abscess injury
PVL-positive S. aureus strains are strongly associated with severe and recurrent furunculosis, consistent with toxin-amplified neutrophilic tissue injury and abscess formation.
neutrophil link
neutrophil activation link
Show evidence (2 references)
PMID:22803835 SUPPORT In Vitro
"PVL is associated with follicular infections in general, having its strongest association with furunculosis and its recurrence."
Supports PVL as a key virulence driver of recurrent furunculosis.
PMID:23973399 SUPPORT Human Clinical
"The study revealed a high prevalence of luk-PV gene among methicillin-susceptible strains and a statistically significant correlation between the presence of this gene and presenting with an abscess."
Correlates PVL gene carriage with abscess phenotype in human carriers.
Adhesin-enriched follicular attachment
Chronic furunculosis isolates commonly harbor adhesin- and toxin-related virulence genes that support stable host-surface attachment and early lesion persistence.
cell adhesion involved in biofilm formation link
hair follicle link
Show evidence (1 reference)
DOI:10.3390/pathogens14090923 SUPPORT Human Clinical
"In 90% of cases, S. aureus strains possessed the following virulence genes: clfA, clfB, spa, cna, eap, hlgA, hlgB, hlg, hld, bap, bbp, ebpS, fib, fnbA, fnbB, and pvl."
Demonstrates high prevalence of adhesion-associated virulence repertoire in chronic furunculosis isolates.
Single-species biofilm establishment in chronic furunculosis lesions
S. aureus strains in chronic furunculosis show direct evidence of biofilm capacity, reinforcing lesion chronicity and tolerance to eradication.
biofilm formation link single-species biofilm formation link
Show evidence (1 reference)
DOI:10.3390/pathogens14090923 SUPPORT Human Clinical
"Biofilm production was confirmed using the crystal violet method."
Provides direct experimental support for biofilm-forming capability in the chronic furunculosis isolate set.
MSSA-dominant persistent virulence reservoir
Chronic furunculosis is predominantly MSSA-driven, but those MSSA strains can retain virulence repertoires similar to MRSA, sustaining relapse risk.
single-species biofilm formation link
Show evidence (2 references)
DOI:10.3390/pathogens14090923 SUPPORT Human Clinical
"It has been demonstrated that MSSA possesses a similar set of virulence genes to MRSA and that MSSA is responsible for most cases of chronic osteomyelitis and furunculosis."
Supports MSSA as a persistent, high-virulence reservoir in chronic furunculosis.
DOI:10.3390/pathogens14090923 SUPPORT Human Clinical
"The findings indicate that S. aureus possesses numerous virulence factors that play a key role in the processes of adhesion to and proliferation within host cells."
Supports ongoing host persistence potential that can sustain chronic recurrence dynamics.
Early keratinocyte-neutrophil innate immune activation
Initial host response to staphylococcal follicular infection is dominated by keratinocyte and neutrophil activation in the affected skin compartment.
keratinocyte link neutrophil link
activation of innate immune response link innate immune response link
Show evidence (1 reference)
DOI:10.3390/antibiotics12030557 SUPPORT Human Clinical
"The immune response to S. aureus SSTIs involves initial responders such as keratinocytes and neutrophils, which are supported by dendritic cells and T-lymphocytes later during infection."
Supports early innate phase dominated by keratinocytes and neutrophils.
Dendritic-cell and T-cell adaptive immune phase
As lesions evolve, dendritic cells and T lymphocytes contribute to adaptive immune orchestration of the ongoing inflammatory response.
dendritic cell link T cell link
adaptive immune response link regulation of T cell differentiation link
Show evidence (1 reference)
DOI:10.3390/antibiotics12030557 SUPPORT Human Clinical
"The immune response to S. aureus SSTIs involves initial responders such as keratinocytes and neutrophils, which are supported by dendritic cells and T-lymphocytes later during infection."
Supports the later adaptive phase involving dendritic cells and T cells.
Immune dysregulation sustaining recurrent furunculosis
Chronic/recurrent furunculosis reflects persistent interaction between staphylococcal virulence and dysregulated innate-acquired immune processes.
keratinocyte link dendritic cell link T cell link
innate immune response link adaptive immune response link
Show evidence (1 reference)
DOI:10.1159/000499184 SUPPORT Human Clinical
"Immunological and inflammatory processes of chronic furunculosis are based on the pathogenicity of <i>S. aureus</i> as well as innate and acquired immunity."
Explicitly supports immune-pathogenesis coupling in recurrent furunculosis.
⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.
Pathograph: causal mechanism network for Furunculosis Interactive directed graph showing how pathophysiology mechanisms, phenotypes, genetic factors and variants, experimental models, environmental triggers, and treatments relate through causal and linked edges.
●

Phenotypes

2
Furuncle Dermatologic HP:0020083
Show evidence (1 reference)
DOI:10.1159/000499184 SUPPORT Human Clinical
"The most frequent <i>S. aureus</i> infections include impetigo, folliculitis, furuncles, furunculosis, abscesses, hidradenitis suppurativa, and mastitis."
Furuncles are explicitly listed as frequent S. aureus clinical manifestations within recurrent furunculosis context.
Recurrent cutaneous abscess formation Dermatologic HP:0100838
Show evidence (2 references)
PMID:22803835 SUPPORT Human Clinical
"PVL is associated with follicular infections in general, having its strongest association with furunculosis and its recurrence."
Supports recurrent abscess phenotype linked to PVL-positive furunculosis.
PMID:17479931 SUPPORT Human Clinical
"From January 1998 through December 2004, 42 cases and 59 relapses of furunculosis were identified by active case finding."
Documents repeated relapses as a defining recurrent phenotype.
💊

Treatments

2
Anti-staphylococcal antibiotic therapy
Action: pharmacotherapy MAXO:0000058
Oral anti-staphylococcal therapy is standard for many SSTIs, with parenteral escalation for severe presentations.
Show evidence (1 reference)
DOI:10.3390/antibiotics12030557 SUPPORT Human Clinical
"Treatment for S. aureus SSTIs is usually oral therapy, with parenteral therapy reserved for severe presentations; it ranges from cephalosporins and penicillin agents such as oxacillin, which is generally used for methicillin-sensitive S. aureus (MSSA), to vancomycin for methicillin-resistant S...."
Supports antibiotic treatment strategy and escalation by severity/resistance profile.
Decolonization with intranasal mupirocin and antiseptic body cleansing
Action: pharmacotherapy MAXO:0000058
Combined decolonization protocols (intranasal mupirocin plus disinfecting washes/antiseptics) are used to interrupt recurrent transmission cycles.
Show evidence (2 references)
PMID:17479931 SUPPORT Human Clinical
"Nasally colonized persons, persons who had current furuncles or who had experienced relapsing furuncles since 2002, and their family members underwent stringent decolonization measures using mupirocin nasal ointment and disinfecting wash solution."
Documents practical outbreak-control use of mupirocin plus antiseptic washing in recurrent furunculosis.
PMID:38518792 SUPPORT Human Clinical
"Current decolonisation procedures include antibiotic-based and antiseptic-based eradication of S aureus from the nose and skin."
Supports decolonization as a prevention/treatment adjunct focused on reservoir eradication.
🌍

Environmental Factors

2
Close contact with affected individuals
Community/household exposure to active cases increases furunculosis risk.
Show evidence (1 reference)
PMID:17479931 SUPPORT Human Clinical
"Risk of furunculosis was associated with contact with case patients (relative risk, 6.8; 95% confidence interval, 3.2-14.3) and nasal colonization with a lukS-lukF-positive strain of S. aureus (relative risk, 3.6; 95% confidence interval, 2.3-5.9)."
Quantifies contact and colonization as epidemiologic risk factors.
Persistent asymptomatic S. aureus carriage
Ongoing colonization of nose/skin reservoirs promotes relapse after apparent resolution.
Show evidence (1 reference)
PMID:38518792 SUPPORT Human Clinical
"Because S aureus infections commonly arise from asymptomatic colonisation, decolonisation is considered a key approach for their prevention."
Indicates asymptomatic carriage is a key upstream determinant of recurrent disease episodes.
🔀

Differential Diagnoses

2

Conditions with similar clinical presentations that must be differentiated from Furunculosis:

Folliculitis MONDO:0006552
Overlapping Features Superficial follicular inflammation that can precede but is usually less deep than furunculosis.
Distinguishing Features
  • Furunculosis involves deeper suppurative abscess formation and recurrent boils.
Show evidence (1 reference)
DOI:10.1159/000499184 SUPPORT Human Clinical
"The most frequent <i>S. aureus</i> infections include impetigo, folliculitis, furuncles, furunculosis, abscesses, hidradenitis suppurativa, and mastitis."
Supports folliculitis as a clinically overlapping S. aureus-related condition in the differential.
Hidradenitis suppurativa MONDO:0006559
Overlapping Features Chronic inflammatory nodules and sinus tracts in intertriginous areas can mimic recurrent boils.
Distinguishing Features
  • Typical distribution in apocrine-rich intertriginous regions with sinus tract/scarring pattern.
Show evidence (1 reference)
DOI:10.1159/000499184 SUPPORT Human Clinical
"The most frequent <i>S. aureus</i> infections include impetigo, folliculitis, furuncles, furunculosis, abscesses, hidradenitis suppurativa, and mastitis."
Supports hidradenitis suppurativa as an overlapping cutaneous condition considered alongside furunculosis.
🔬

Clinical Trials

3
NCT00513799 NOT_APPLICABLE COMPLETED
Randomized decolonization strategy study in community-associated S. aureus skin and soft tissue infections, including furunculosis, with follow-up for recurrence prevention.
Target Phenotypes: Furuncle ↗ Recurrent cutaneous abscess formation ↗
Show evidence (2 references)
clinicaltrials:NCT00513799 SUPPORT Human Clinical
"The purpose of this study is to determine the natural history of community-associated Staphylococcus aureus infections in both adult and pediatric patients by monitoring the rate of recurrent infections in those colonized with S. aureus."
Directly addresses recurrence dynamics relevant to recurrent furunculosis.
clinicaltrials:NCT00513799 SUPPORT Human Clinical
"In addition, this study will evaluate the efficiency of commonly prescribed decolonization measures in patients presenting with S. aureus skin and soft tissue infections."
Supports clinical trial evaluation of decolonization strategies in furunculosis-relevant SSTIs.
NCT01814371 NOT_APPLICABLE COMPLETED
Trial comparing individualized versus household decolonization approaches to prevent recurrent S. aureus skin infections in households with prior SSTI.
Target Phenotypes: Furuncle ↗ Recurrent cutaneous abscess formation ↗
Show evidence (1 reference)
clinicaltrials:NCT01814371 SUPPORT Human Clinical
"The purpose of this research study is to compare the effectiveness of commonly used decolonization treatments (application of mupirocin antibiotic ointment to the nose and bleach baths) when performed by individuals with a history of skin and soft tissue infection (SSTI) in the prior year..."
Directly evaluates recurrence-prevention strategies in the furunculosis-relevant SSTI population.
NCT00731783 NOT_APPLICABLE COMPLETED
Household-versus-individual S. aureus decolonization trial assessing eradication success and prevention of future staphylococcal skin infections.
Target Phenotypes: Furuncle ↗ Recurrent cutaneous abscess formation ↗
Show evidence (1 reference)
clinicaltrials:NCT00731783 SUPPORT Human Clinical
"The purpose of this study is to determine whether measures to eliminate the Staph germ from the skin of the index patient (with a special ointment and soap) are more effective when performed by everyone in the household rather than the patient alone, and whether these methods are effective in..."
Supports practical household-level decolonization interventions intended to prevent recurrent furunculosis-like infections.
📚

Literature Summaries

1
Falcon ▸
Disease Pathophysiology Research Template
Edison Scientific Literature 38 citations 2026-02-18T18:35:28.259325

Question: You are an expert researcher providing comprehensive, well-cited information.

Provide detailed information focusing on: 1. Key concepts and definitions with current understanding 2. Recent developments and latest research (prioritize 2023-2024 sources) 3. Current applications and real-world implementations 4. Expert opinions and analysis from authoritative sources 5. Relevant statistics and data from recent studies

Format as a comprehensive research report with proper citations. Include URLs and publication dates where available. Always prioritize recent, authoritative sources and provide specific citations for all major claims.

Disease Pathophysiology Research Template

Target Disease

  • Disease Name: Furunculosis
  • MONDO ID: (if available)
  • Category: Infectious Disease

Research Objectives

Please provide a comprehensive research report on the pathophysiology of Furunculosis. Focus on the molecular and cellular mechanisms underlying disease progression.

Required Information

1. Core Pathophysiology

  • What are the primary pathophysiological mechanisms?
  • What molecular pathways are dysregulated?
  • What cellular processes are affected?

2. Key Molecular Players

  • Genes/Proteins: Which genes are causally involved or implicated?
  • Chemical Entities: What metabolites, drugs, or small molecules are relevant?
  • Cell Types: Which cell types are primarily affected?
  • Anatomical Locations: Which tissues/organs are involved?

3. Biological Processes (for GO annotation)

  • What biological processes (GO terms) are disrupted?
  • Consider: signaling pathways, metabolic processes, cellular responses, transport, etc.

4. Cellular Components

  • Where in the cell do key processes occur?
  • Consider: organelles, membrane compartments, extracellular space, etc.

5. Disease Progression

  • What is the sequence of events from initial trigger to clinical manifestation?
  • Are there distinct stages or phases?

6. Phenotypic Manifestations

  • What are the key clinical phenotypes?
  • How do they relate to the underlying mechanisms?

Citation Requirements

  • Cite primary literature (PMID preferred) for all mechanistic claims
  • Prioritize recent reviews and landmark papers
  • Include direct quotes where possible to support key statements

Output Format

Structure your response as a narrative that could be used to populate a disease knowledge base entry with: - Pathophysiology description - Gene/protein annotations with ontology terms (HGNC, GO) - Phenotype associations (HP terms) - Cell type involvement (CL terms) - Anatomical locations (UBERON terms) - Chemical entities (CHEBI terms) - Evidence items with PMIDs

Comprehensive Research Report: Pathophysiology of Furunculosis (Infectious Disease)

Publication date: 2026-02-18

  1. Key concepts and definitions (current understanding)

Terminology and scope “Furunculosis” is used in two distinct biomedical contexts:

A. Human furunculosis (recurrent/chronic furunculosis): a deep bacterial infection of the hair follicle leading to a localized abscess (furuncle/boil). In a contemporary SSTI review, furunculosis is described as a deep folliculitis with “localized abscesses in the hypodermis” and tender erythematous nodules with a central pustule, most often caused by Staphylococcus aureus. (linz2023clinicalimpactof pages 3-5)

B. Fish (salmonid) furunculosis: a septicemic disease of fish caused by Aeromonas salmonicida, commonly producing systemic hemorrhage/necrosis and high mortality in aquaculture. (nikiforovnikishin2025dynamicsofpathomorphological pages 1-2, ahmed2025anoverviewon pages 15-17)

Ontology identifiers No MONDO identifier for “furunculosis” could be confirmed from the retrieved sources alone. The term should be represented as two disease entities in a knowledge base: (i) human S. aureus furunculosis (skin abscess/furuncle) and (ii) fish furunculosis due to A. salmonicida. (nikiforovnikishin2025dynamicsofpathomorphological pages 1-2, linz2023clinicalimpactof pages 3-5)

  1. Core pathophysiology (molecular and cellular mechanisms)

2A. Human furunculosis (S. aureus): host–pathogen interaction model

Initial trigger and colonization-to-infection transition Human recurrent furunculosis is tightly linked to colonization reservoirs. Chronic/recurrent furunculosis is “strongly associated with nasal carriage of S. aureus.” (linz2023clinicalimpactof pages 3-5) A high-authority 2024 review emphasizes that S. aureus colonization often precedes infection and that non-skin reservoirs (especially nose and intestine) can “seed recurrent infections.” (piewngam2024staphylococcusaureuscolonisation pages 1-3)

Colonization burden and sites (quantitative) Nasal carriage burden is reported as ~10^2–10^6 CFU/swab (average ~10^4–10^5), while fecal counts are ~10^6–10^7 CFU per 100 g; intestinal burdens may exceed nasal burdens by orders of magnitude. (piewngam2024staphylococcusaureuscolonisation pages 3-4, piewngam2024staphylococcusaureuscolonisation media e0c0446d) Permanent carriers are ~20% and intermittent carriers ~30%. (piewngam2024staphylococcusaureuscolonisation pages 3-4)

Epithelial barrier engagement and innate sensing Keratinocytes and neutrophils dominate early responses in S. aureus SSTIs; dendritic cells and T cells contribute later. (linz2023clinicalimpactof pages 1-2) Innate recognition includes TLR2 and NOD2; NOD2 deletion increased bacterial burden 5–10× and increased NF-κB activity in cited experimental systems, supporting NOD2-mediated antibacterial defense in skin infection. (linz2023clinicalimpactof pages 10-11)

Abscess formation and immune evasion: a “contained infection” strategy S. aureus uses coagulases (Coa) and vWbp to activate prothrombin and generate fibrin, contributing to “abscess capsule formation” (a fibrin/host-derived barrier that can protect bacteria from immune clearance). (linz2023clinicalimpactof pages 10-11) Protein A (SpA) supports immune evasion by binding IgG and can act as a B-cell superantigen, hindering effective adaptive responses; SpA also interacts with TNFR1 and alters keratinocyte cytokine responses. (linz2023clinicalimpactof pages 10-11)

Tissue damage and cytotoxicity Panton–Valentine leukocidin (PVL) is described as a “cytotoxic virulence factor” and is strongly associated with furunculosis pathogenesis; reported PVL positivity in furunculosis is 40–90%. (linz2023clinicalimpactof pages 3-5) Alpha-hemolysin (Hla) binds ADAM10; ADAM10 cleavage of E-cadherin disrupts epithelial adhesion and migration. Hla also induces keratinocyte necrosis via a Ca2+-dependent calpain pathway and is required for keratinocyte invasion in cited models. (linz2023clinicalimpactof pages 5-7, linz2023clinicalimpactof pages 10-11)

Biofilm-associated persistence and chronicity Biofilm formation in SSTIs can occur via ica-dependent (PIA) and ica-independent mechanisms involving protein A, fibronectin-binding proteins, autolysin, extracellular DNA, and Bap. (linz2023clinicalimpactof pages 10-11) Clinical isolates from chronic furunculosis commonly carry adhesins and biofilm/toxin genes, including bap (biofilm-associated protein) and pvl, supporting a mechanistic basis for recurrence/persistence through adhesion, toxin-driven inflammation, and biofilm-associated tolerance. (wcisłek2025phenotypicandgenotypic pages 12-13, wcisłek2025phenotypicandgenotypic pages 15-17)

Inflammatory signaling and cell recruitment During SSTI progression, early cytokines include IL-6, CXCL1, CCL2/3, G-CSF, GM-CSF, and IL-1β; later IL-17A/F rise, consistent with a Th17-skewed antibacterial response. (linz2023clinicalimpactof pages 10-11) IL-33 is described as promoting ROS and NETs; basophil-derived IL-4 can suppress IL-17-mediated defenses, suggesting a mechanism for impaired clearance in some host states. (linz2023clinicalimpactof pages 10-11)

Immune dysregulation in chronic disease A recurrent furunculosis-focused review describes chronic furunculosis as a “complex mechanism based on S. aureus pathogenicity interacting with innate and adaptive immunity.” (nowicka2019staphylococcusaureusand pages 8-9) It also highlights superantigenic enterotoxins as drivers of broad T-cell activation and downstream exhaustion/anergy, which can promote immune evasion and chronicity. (nowicka2019staphylococcusaureusand pages 8-9)

2B. Fish furunculosis (A. salmonicida): systemic cytotoxic sepsis model

Pathogen determinants and delivery systems A. salmonicida strains can encode adhesion systems (type IV pili, fimbriae), toxins (aerolysin, hemolysins), and secretion systems such as type II secretion (T2SS); one experimental strain lacking T3SS was hypothesized to rely on T2SS-mediated exotoxin secretion leading to systemic cytotoxic damage. (nikiforovnikishin2025dynamicsofpathomorphological pages 1-2) Other A. salmonicida virulence determinants highlighted in outbreak-focused genomics include T3SS components (AscC) and effector AexT on plasmid pAsa5; loss of the virulence plasmid can lead to avirulence, emphasizing plasmid-mediated virulence plasticity. (wojnarowski2024genomicanalysisof pages 11-12, wojnarowski2024genomicanalysisof pages 15-15)

Host tissue injury and septicaemia Fish furunculosis is described as acute or chronic hemorrhagic septicemia with “widespread liquefactive necrosis,” external furuncles/ulcers and internal hemorrhages, with multi-organ pathology (e.g., splenomegaly, hepatic necrosis/hemorrhage, peritonitis, gill epithelial death and lamellar fusion, renal and intestinal epithelial collapse). (ahmed2025anoverviewon pages 15-17)

Staged disease progression with biochemical correlates (experimental) In an in vivo rainbow trout infection model, the 4-day LD50 was 1.63 × 10^6 CFU/fish. Disease progressed through three stages: early (1–2 days post-infection) with maximal bacterial load and nonspecific immunity activation; acute stage (4 days) with severe septicemia and anemia plus systemic organ damage with peak AST/ALT; and recovery (6 days) with partial inflammation regression but persistent liver/kidney dysfunction. (nikiforovnikishin2025dynamicsofpathomorphological pages 1-2)

  1. Key molecular players (genes/proteins, cell types, anatomical locations, chemicals)

3A. Human furunculosis (S. aureus)

Pathogen genes/proteins (examples; mechanisms supported in reviews and isolate studies) Toxins/cytolysins: PVL (lukS-PV/lukF-PV), α-hemolysin (hla), γ-hemolysin (hlg), δ-hemolysin (hld). (linz2023clinicalimpactof pages 5-7, linz2023clinicalimpactof pages 3-5, wcisłek2025phenotypicandgenotypic pages 15-17) Immune evasion/abscess architecture: coagulase (coa), von Willebrand factor-binding protein (vWbp), Protein A (spa). (linz2023clinicalimpactof pages 10-11, wcisłek2025phenotypicandgenotypic pages 15-17) Adhesins: clumping factor B (clfB; binds SREC-1 and cytokeratin 10 in colonization models), fibronectin-binding proteins (fnbA/fnbB), collagen-binding adhesin (cna), extracellular adherence protein (eap). (piewngam2024staphylococcusaureuscolonisation pages 3-4, wcisłek2025phenotypicandgenotypic pages 12-13, wcisłek2025phenotypicandgenotypic pages 15-17) Biofilm: ica/PIA pathway, Bap (bap), extracellular DNA. (linz2023clinicalimpactof pages 10-11, wcisłek2025phenotypicandgenotypic pages 15-17) Regulatory: Agr quorum sensing affects colonization (notably intestinal) and virulence phenotypes. (piewngam2024staphylococcusaureuscolonisation pages 3-4)

Host pathways and immune mediators Pattern recognition: TLR2; NOD2 → NF-κB signaling and antibacterial control. (linz2023clinicalimpactof pages 10-11) Cytokines/chemokines: IL-1β, IL-6, CXCL1, G-CSF/GM-CSF early; IL-17A/F later. (linz2023clinicalimpactof pages 10-11) Barrier/adhesion: ADAM10 and E-cadherin cleavage downstream of Hla. (linz2023clinicalimpactof pages 5-7) Checkpoint/exhaustion concepts and superantigen effects are implicated in chronicity. (nowicka2019staphylococcusaureusand pages 8-9)

Cell types (CL terms; principal participants) Keratinocytes (CL:0000312): first responders; internalization/proinflammatory signaling to S. aureus. (linz2023clinicalimpactof pages 1-2, linz2023clinicalimpactof pages 10-11) Neutrophils (CL:0000775): early dominant infiltrate; targeted by PVL and leukotoxins. (linz2023clinicalimpactof pages 1-2, linz2023clinicalimpactof pages 3-5) Macrophages (CL:0000235), dendritic cells (CL:0000451): later stages and antigen presentation. (linz2023clinicalimpactof pages 1-2, linz2023clinicalimpactof pages 10-11) T lymphocytes (CL:0000084), including Th17-like responses (functional): later cytokine phases. (linz2023clinicalimpactof pages 10-11)

Anatomical locations (UBERON) Hair follicle (UBERON:0002076) and hypodermis/subcutis (UBERON:0002193): core lesion site (“localized abscesses in the hypodermis”). (linz2023clinicalimpactof pages 3-5) Common clinical sites: axilla and groin regions (moist skin colonization sites), gluteal region; nose and intestine are key reservoirs. (linz2023clinicalimpactof pages 3-5, piewngam2024staphylococcusaureuscolonisation pages 1-3, piewngam2024staphylococcusaureuscolonisation pages 4-6)

Relevant chemical entities (CHEBI; examples from prevention/treatment context) Mupirocin (CHEBI:7025), chlorhexidine (CHEBI:3563), povidone-iodine/iodine (CHEBI:24859): common decolonization agents. (piewngam2024staphylococcusaureuscolonisation pages 6-7, piewngam2024staphylococcusaureuscolonisation pages 7-9, piewngam2024staphylococcusaureuscolonisation media 776be3f3)

3B. Fish furunculosis (A. salmonicida)

Pathogen factors Toxins: aerolysin, hemolysins; secretion: T2SS (in some strains). (nikiforovnikishin2025dynamicsofpathomorphological pages 1-2) T3SS machinery and effectors: AscC (pore), AexT (effector) often plasmid-associated; plasmid instability can alter virulence. (wojnarowski2024genomicanalysisof pages 11-12, wojnarowski2024genomicanalysisof pages 15-15) Outer membrane proteins as immunogens: OmpA, OmpC, OmpF; antigenic variation can occur (e.g., vapA-absent strains impacting diagnostics/vaccination). (wojnarowski2024genomicanalysisof pages 6-11, wojnarowski2024genomicanalysisof pages 11-12, mancilla2025majorantigenicdifferences pages 1-2)

Host tissues Gills (UBERON:0002535), kidney (UBERON:0002113), liver (UBERON:0002107), spleen (UBERON:0002106), intestine (UBERON:0000160): major target organs with characteristic pathology. (ahmed2025anoverviewon pages 15-17)

  1. Biological processes (GO-style annotations; disrupted processes)

Human furunculosis (S. aureus) — candidate GO process mapping grounded in cited mechanisms Innate immune response / pattern recognition receptor signaling (e.g., “TLR2 and NOD2 … NF-κB activity”). (linz2023clinicalimpactof pages 10-11) Neutrophil chemotaxis and activation (early neutrophil predominance; CXCL1, G-CSF). (linz2023clinicalimpactof pages 1-2, linz2023clinicalimpactof pages 10-11) IL-17-mediated signaling and antibacterial defense (later IL-17A/F). (linz2023clinicalimpactof pages 10-11) Biofilm formation and extracellular matrix adhesion (PIA/ica-dependent and independent biofilm; fnbA/B; bap). (linz2023clinicalimpactof pages 10-11, wcisłek2025phenotypicandgenotypic pages 15-17) Host cell–cell adhesion maintenance/disruption (Hla→ADAM10→E-cadherin cleavage). (linz2023clinicalimpactof pages 5-7)

Fish furunculosis (A. salmonicida) Response to bacterium and systemic inflammatory response (nonspecific immunity activation early; septicemia). (nikiforovnikishin2025dynamicsofpathomorphological pages 1-2) Cytolysis/toxin-mediated tissue injury (exotoxin-driven cytotoxic damage). (nikiforovnikishin2025dynamicsofpathomorphological pages 1-2) Antigen processing and presentation / adaptive activation following vaccination (see Section 5 for vaccine-induced gene upregulation). (xiu2024evaluationofimmune pages 8-10)

  1. Cellular components (where key processes occur)

Human Extracellular space and bacterial surface: adhesins (ClfB/Fnb) binding host receptors and matrix; coagulase activity driving fibrin deposition around abscesses. (linz2023clinicalimpactof pages 10-11, piewngam2024staphylococcusaureuscolonisation pages 3-4) Plasma membrane: Hla interaction with ADAM10; disruption of E-cadherin junctions. (linz2023clinicalimpactof pages 5-7) Biofilm matrix: extracellular DNA, polysaccharides (PIA), and biofilm proteins (Bap). (linz2023clinicalimpactof pages 10-11, wcisłek2025phenotypicandgenotypic pages 15-17)

Fish Secreted toxin compartment: T2SS-mediated exotoxin export (for strains lacking T3SS). (nikiforovnikishin2025dynamicsofpathomorphological pages 1-2) Plasmid-encoded secretion systems: T3SS apparatus/effectors (AscC/AexT) associated with pAsa5. (wojnarowski2024genomicanalysisof pages 11-12)

  1. Disease progression (sequence of events)

6A. Human furunculosis (S. aureus)

A practical mechanistic sequence consistent with current reviews: Reservoir colonization (nose ± intestine ± moist skin sites such as axilla/groin) with measurable CFU burdens and carrier states. (piewngam2024staphylococcusaureuscolonisation pages 3-4, piewngam2024staphylococcusaureuscolonisation pages 1-3, piewngam2024staphylococcusaureuscolonisation pages 4-6) Breach/follicular invasion leading to deep folliculitis and hypodermal abscess formation (furuncle). (linz2023clinicalimpactof pages 3-5) Early innate response dominated by keratinocytes and neutrophils, with PRR signaling (TLR2/NOD2) and strong IL-1β/IL-6/CXCL1/G-CSF induction. (linz2023clinicalimpactof pages 1-2, linz2023clinicalimpactof pages 10-11) Bacterial immune evasion and lesion maturation through toxins (PVL/Hla), abscess encapsulation (Coa/vWbp), and biofilm formation; later involvement of macrophages/dendritic cells/T cells and IL-17A/F responses. (linz2023clinicalimpactof pages 10-11, linz2023clinicalimpactof pages 3-5) Recurrence/chronicity promoted by persistent colonization (re-seeding from reservoirs), biofilm-associated tolerance, and immune dysregulation (e.g., superantigen-driven T-cell exhaustion/anergy). (nowicka2019staphylococcusaureusand pages 8-9, piewngam2024staphylococcusaureuscolonisation pages 1-3, linz2023clinicalimpactof pages 10-11)

6B. Fish furunculosis (A. salmonicida)

Experimental staging data: Early stage (1–2 DPI): maximal bacterial load; nonspecific immunity activation. (nikiforovnikishin2025dynamicsofpathomorphological pages 1-2) Acute stage (4 DPI): severe septicemia and anemia; systemic organ damage with AST/ALT peaks. (nikiforovnikishin2025dynamicsofpathomorphological pages 1-2) Recovery stage (6 DPI): partial regression of inflammation but persistent liver/kidney dysfunction. (nikiforovnikishin2025dynamicsofpathomorphological pages 1-2)

  1. Phenotypic manifestations (clinical phenotypes and mechanistic links)

7A. Human phenotypes (HP-style; examples) Furuncle/boil phenotype: tender erythematous nodule with central pustule; mechanistically linked to follicular invasion, neutrophilic inflammation, toxin-driven necrosis, and fibrin-encapsulated abscess formation. (linz2023clinicalimpactof pages 3-5, linz2023clinicalimpactof pages 10-11) Recurrent boils and outbreaks: associated with PVL-positive S. aureus strains and colonization reservoirs. (linz2023clinicalimpactof pages 3-5, piewngam2024staphylococcusaureuscolonisation pages 1-3) Carbuncle (coalescing furuncles) with deeper extension and possible sinus tracts; increased frequency in immunodeficiency contexts (e.g., hypogammaglobulinemia, chronic granulomatous disease). (linz2023clinicalimpactof pages 3-5)

7B. Fish phenotypes External furuncles/ulcers and internal hemorrhages with septicemia; multi-organ necrosis and anemia (acute stage). (nikiforovnikishin2025dynamicsofpathomorphological pages 1-2, ahmed2025anoverviewon pages 15-17)

  1. Recent developments (prioritizing 2023–2024) and authoritative expert analysis

8A. Human (2023–2024)

Updated epidemiology and burden (2023) A 2023 review reports that recurrent SSTIs affect ~16–19% of healthy adults. (linz2023clinicalimpactof pages 1-2) Hospitalization trends: MRSA SSTI hospitalizations declined from 3.8 to 3.0 per 1000 by 2014 and from 1.72 per 1000 (2016) to 1.32 per 1000 (2019) in U.S. datasets summarized in the review. (linz2023clinicalimpactof pages 1-2) Global burden estimates summarized include >1,105,000 deaths attributed to S. aureus in 2019 and >100,000 deaths to MRSA in 2019; SSTI age-standardized mortality rate is given as 0.5. (linz2023clinicalimpactof pages 16-17, linz2023clinicalimpactof pages 2-3)

Contemporary mechanistic synthesis (2023) Mechanistic pathways emphasized in 2023 include Hla–ADAM10–E-cadherin disruption, NOD2/NF-κB control of bacterial burden, and a time-phased cytokine program shifting toward IL-17A/F responses. (linz2023clinicalimpactof pages 5-7, linz2023clinicalimpactof pages 10-11)

Expert review perspective on colonization and prevention (2024) A Lancet Microbe 2024 review underscores that “most infections arise from asymptomatic colonization,” positioning decolonization as a primary prevention lever, while noting controversial effectiveness, increasing resistance, and recolonization from extranasal reservoirs. (piewngam2024staphylococcusaureuscolonisation pages 1-3, piewngam2024staphylococcusaureuscolonisation pages 6-7) The same review summarizes that ~80% of infectious isolates match colonizing strains, reinforcing the colonization→infection paradigm central to recurrent furunculosis. (piewngam2024staphylococcusaureuscolonisation pages 4-6) Emerging, less microbiome-disruptive approaches include bacteriocin-producing commensals and probiotic strategies; in one cited trial, oral Bacillus subtilis spores eliminated “>95% of bodily S. aureus” without altering gut microbiota. (piewngam2024staphylococcusaureuscolonisation pages 9-11)

8B. Fish/aquaculture (2024)

Genomics-enabled outbreak management and vaccine strategy A 2024 Pathogens study used nanopore WGS of 54 A. salmonicida isolates and concluded outbreaks likely represent a “single epidemiological unit,” and that “major immunogenic proteins … are highly conservative,” supporting consensus-isolate autogenous vaccine design; it also warns of plasmid-driven plasticity. (wojnarowski2024genomicanalysisof pages 12-13, wojnarowski2024genomicanalysisof pages 1-2)

Vaccination immunology and efficacy metrics A 2024 Fishes study of a bivalent inactivated vaccine (A. salmonicida + V. vulnificus; Montanide ISA 763 AVG) reported RPS ~77% and measured upregulation of TLR5, MHCI, MHCII, and CD4 in kidney, alongside increased lysozyme and acid phosphatase activities and elevated antibody titers. (xiu2024evaluationofimmune pages 8-10, xiu2024evaluationofimmune pages 6-8)

  1. Current applications and real-world implementations

Human healthcare Decolonization protocols: mupirocin (typically 5-day intranasal course) plus skin antiseptics (chlorhexidine/povidone-iodine) are standard tools but limited by recolonization (often by 3 months), incomplete extranasal clearance, and resistance concerns. (piewngam2024staphylococcusaureuscolonisation pages 6-7, piewngam2024staphylococcusaureuscolonisation pages 7-9) Program-level strategies: large trials summarized in 2024 include CLEAR (post-discharge decolonization + hygiene reduced MRSA infection by 30% over one year) and REDUCE-MRSA (universal decolonization reducing MRSA cultures more than targeted approaches, with mixed results for bloodstream infections). (piewngam2024staphylococcusaureuscolonisation pages 7-9)

Aquaculture Routine vaccination and adjuvanted inactivated vaccines are implemented for furunculosis prevention, with measurable survival benefits (e.g., RPS ~77% in turbot vaccine study). (xiu2024evaluationofimmune pages 8-10) Operational genomics: nanopore WGS is proposed as a practical field-forward method to rapidly characterize outbreak isolates and justify autogenous vaccines across multiple facilities under regulatory scrutiny. (wojnarowski2024genomicanalysisof pages 1-2)

  1. Evidence items (with publication dates, URLs)

Human furunculosis/S. aureus Linz MS et al. “Clinical Impact of Staphylococcus aureus Skin and Soft Tissue Infections.” Antibiotics. 2023-03. DOI:10.3390/antibiotics12030557 https://doi.org/10.3390/antibiotics12030557 (linz2023clinicalimpactof pages 1-2, linz2023clinicalimpactof pages 10-11, linz2023clinicalimpactof pages 3-5) Piewngam P, Otto M. “Staphylococcus aureus colonisation and strategies for decolonisation.” The Lancet Microbe. 2024-06. DOI:10.1016/S2666-5247(24)00040-5 https://doi.org/10.1016/S2666-5247(24)00040-5 (piewngam2024staphylococcusaureuscolonisation pages 1-3, piewngam2024staphylococcusaureuscolonisation pages 6-7, piewngam2024staphylococcusaureuscolonisation pages 7-9) Nowicka D, Grywalska E. “Staphylococcus aureus and Host Immunity in Recurrent Furunculosis.” Dermatology. 2019-04. DOI:10.1159/000499184 https://doi.org/10.1159/000499184 (nowicka2019staphylococcusaureusand pages 2-4, nowicka2019staphylococcusaureusand pages 8-9)

Fish furunculosis/A. salmonicida Xiu Y et al. “Evaluation of Immune Protection of a Bivalent Inactivated Vaccine against Aeromonas salmonicida and Vibrio vulnificus in Turbot.” Fishes. 2024-04. DOI:10.3390/fishes9040131 https://doi.org/10.3390/fishes9040131 (xiu2024evaluationofimmune pages 8-10, xiu2024evaluationofimmune pages 6-8) Wojnarowski K et al. “Genomic Analysis of Aeromonas salmonicida ssp. salmonicida Isolates…” Pathogens. 2024-10. DOI:10.3390/pathogens13100908 https://doi.org/10.3390/pathogens13100908 (wojnarowski2024genomicanalysisof pages 12-13, wojnarowski2024genomicanalysisof pages 11-12, wojnarowski2024genomicanalysisof pages 1-2)

  1. Limitations relative to the requested PMID-centric output The retrieved evidence set contains high-quality reviews and recent aquaculture studies but does not provide PMIDs in the extracted text snippets, and several key mechanistic primary studies are referenced only indirectly within those reviews. Therefore, mechanistic claims are supported here by DOI-cited sources; additional PMID-level extraction would require retrieving and parsing the underlying primary studies cited within these reviews.

Image evidence S. aureus colonization burden/sites schematic and decolonization intervention figure(s) from Piewngam & Otto (Lancet Microbe 2024) are available as cropped figures. (piewngam2024staphylococcusaureuscolonisation media e0c0446d, piewngam2024staphylococcusaureuscolonisation media 776be3f3)

References

  1. (linz2023clinicalimpactof pages 3-5): Matthew S. Linz, Arun Mattappallil, Diana Finkel, and Dane Parker. Clinical impact of staphylococcus aureus skin and soft tissue infections. Antibiotics, 12:557, Mar 2023. URL: https://doi.org/10.3390/antibiotics12030557, doi:10.3390/antibiotics12030557. This article has 274 citations.

  2. (nikiforovnikishin2025dynamicsofpathomorphological pages 1-2): Dmitry Nikiforov-Nikishin, Nikita Kochetkov, Kirill Gavrilin, Viktoria Gaffarova, Kirill Medvedev, Svetlana Smorodinskaya, Anastasia Klimuk, Yuri Kuchikhin, Ivan Svinarev, Natalya Gladysh, Anna Kudryavtseva, Egor Shitikov, and Alexei Nikiforov-Nikishin. Dynamics of pathomorphological and pathophysiological alterations in rainbow trout (oncorhynchus mykiss) during acute aeromonas salmonicida infection. Biology, 14:1330, Sep 2025. URL: https://doi.org/10.3390/biology14101330, doi:10.3390/biology14101330. This article has 1 citations.

  3. (ahmed2025anoverviewon pages 15-17): Imtiaz Ahmed, Shagufta Ishtiyaq, and Shabihul Fatma Sayed. An overview on understanding the major bacterial fish diseases in freshwater salmonids. Frontiers in Aquaculture, Mar 2025. URL: https://doi.org/10.3389/faquc.2025.1515831, doi:10.3389/faquc.2025.1515831. This article has 8 citations.

  4. (piewngam2024staphylococcusaureuscolonisation pages 1-3): Pipat Piewngam and Michael Otto. Staphylococcus aureus colonisation and strategies for decolonisation. The Lancet Microbe, 5:e606-e618, Jun 2024. URL: https://doi.org/10.1016/s2666-5247(24)00040-5, doi:10.1016/s2666-5247(24)00040-5. This article has 143 citations.

  5. (piewngam2024staphylococcusaureuscolonisation pages 3-4): Pipat Piewngam and Michael Otto. Staphylococcus aureus colonisation and strategies for decolonisation. The Lancet Microbe, 5:e606-e618, Jun 2024. URL: https://doi.org/10.1016/s2666-5247(24)00040-5, doi:10.1016/s2666-5247(24)00040-5. This article has 143 citations.

  6. (piewngam2024staphylococcusaureuscolonisation media e0c0446d): Pipat Piewngam and Michael Otto. Staphylococcus aureus colonisation and strategies for decolonisation. The Lancet Microbe, 5:e606-e618, Jun 2024. URL: https://doi.org/10.1016/s2666-5247(24)00040-5, doi:10.1016/s2666-5247(24)00040-5. This article has 143 citations.

  7. (linz2023clinicalimpactof pages 1-2): Matthew S. Linz, Arun Mattappallil, Diana Finkel, and Dane Parker. Clinical impact of staphylococcus aureus skin and soft tissue infections. Antibiotics, 12:557, Mar 2023. URL: https://doi.org/10.3390/antibiotics12030557, doi:10.3390/antibiotics12030557. This article has 274 citations.

  8. (linz2023clinicalimpactof pages 10-11): Matthew S. Linz, Arun Mattappallil, Diana Finkel, and Dane Parker. Clinical impact of staphylococcus aureus skin and soft tissue infections. Antibiotics, 12:557, Mar 2023. URL: https://doi.org/10.3390/antibiotics12030557, doi:10.3390/antibiotics12030557. This article has 274 citations.

  9. (linz2023clinicalimpactof pages 5-7): Matthew S. Linz, Arun Mattappallil, Diana Finkel, and Dane Parker. Clinical impact of staphylococcus aureus skin and soft tissue infections. Antibiotics, 12:557, Mar 2023. URL: https://doi.org/10.3390/antibiotics12030557, doi:10.3390/antibiotics12030557. This article has 274 citations.

  10. (wcisłek2025phenotypicandgenotypic pages 12-13): Aleksandra Wcisłek, Joanna Jursa-Kulesza, Helena Masiuk, Bartłomiej Grygorcewicz, Beata Hukowska-Szematowicz, Piotr Prowans, Paweł Ziętek, and Danuta Kosik-Bogacka. Phenotypic and genotypic characterization of staphylococcus aureus isolated from patients with chronic furunculosis and osteomyelitis from northwestern poland. Pathogens, 14:923, Sep 2025. URL: https://doi.org/10.3390/pathogens14090923, doi:10.3390/pathogens14090923. This article has 0 citations.

  11. (wcisłek2025phenotypicandgenotypic pages 15-17): Aleksandra Wcisłek, Joanna Jursa-Kulesza, Helena Masiuk, Bartłomiej Grygorcewicz, Beata Hukowska-Szematowicz, Piotr Prowans, Paweł Ziętek, and Danuta Kosik-Bogacka. Phenotypic and genotypic characterization of staphylococcus aureus isolated from patients with chronic furunculosis and osteomyelitis from northwestern poland. Pathogens, 14:923, Sep 2025. URL: https://doi.org/10.3390/pathogens14090923, doi:10.3390/pathogens14090923. This article has 0 citations.

  12. (nowicka2019staphylococcusaureusand pages 8-9): Danuta Nowicka and Ewelina Grywalska. Staphylococcus aureus and host immunity in recurrent furunculosis. Dermatology, 235:295-305, Apr 2019. URL: https://doi.org/10.1159/000499184, doi:10.1159/000499184. This article has 64 citations and is from a peer-reviewed journal.

  13. (wojnarowski2024genomicanalysisof pages 11-12): Konrad Wojnarowski, Paulina Cholewińska, Peter Steinbauer, Tobias Lautwein, Wanvisa Hussein, Lisa-Marie Streb, and Dušan Palić. Genomic analysis of aeromonas salmonicida ssp. salmonicida isolates collected during multiple clinical outbreaks supports association with a single epidemiological unit. Pathogens, 13:908, Oct 2024. URL: https://doi.org/10.3390/pathogens13100908, doi:10.3390/pathogens13100908. This article has 4 citations.

  14. (wojnarowski2024genomicanalysisof pages 15-15): Konrad Wojnarowski, Paulina Cholewińska, Peter Steinbauer, Tobias Lautwein, Wanvisa Hussein, Lisa-Marie Streb, and Dušan Palić. Genomic analysis of aeromonas salmonicida ssp. salmonicida isolates collected during multiple clinical outbreaks supports association with a single epidemiological unit. Pathogens, 13:908, Oct 2024. URL: https://doi.org/10.3390/pathogens13100908, doi:10.3390/pathogens13100908. This article has 4 citations.

  15. (piewngam2024staphylococcusaureuscolonisation pages 4-6): Pipat Piewngam and Michael Otto. Staphylococcus aureus colonisation and strategies for decolonisation. The Lancet Microbe, 5:e606-e618, Jun 2024. URL: https://doi.org/10.1016/s2666-5247(24)00040-5, doi:10.1016/s2666-5247(24)00040-5. This article has 143 citations.

  16. (piewngam2024staphylococcusaureuscolonisation pages 6-7): Pipat Piewngam and Michael Otto. Staphylococcus aureus colonisation and strategies for decolonisation. The Lancet Microbe, 5:e606-e618, Jun 2024. URL: https://doi.org/10.1016/s2666-5247(24)00040-5, doi:10.1016/s2666-5247(24)00040-5. This article has 143 citations.

  17. (piewngam2024staphylococcusaureuscolonisation pages 7-9): Pipat Piewngam and Michael Otto. Staphylococcus aureus colonisation and strategies for decolonisation. The Lancet Microbe, 5:e606-e618, Jun 2024. URL: https://doi.org/10.1016/s2666-5247(24)00040-5, doi:10.1016/s2666-5247(24)00040-5. This article has 143 citations.

  18. (piewngam2024staphylococcusaureuscolonisation media 776be3f3): Pipat Piewngam and Michael Otto. Staphylococcus aureus colonisation and strategies for decolonisation. The Lancet Microbe, 5:e606-e618, Jun 2024. URL: https://doi.org/10.1016/s2666-5247(24)00040-5, doi:10.1016/s2666-5247(24)00040-5. This article has 143 citations.

  19. (wojnarowski2024genomicanalysisof pages 6-11): Konrad Wojnarowski, Paulina Cholewińska, Peter Steinbauer, Tobias Lautwein, Wanvisa Hussein, Lisa-Marie Streb, and Dušan Palić. Genomic analysis of aeromonas salmonicida ssp. salmonicida isolates collected during multiple clinical outbreaks supports association with a single epidemiological unit. Pathogens, 13:908, Oct 2024. URL: https://doi.org/10.3390/pathogens13100908, doi:10.3390/pathogens13100908. This article has 4 citations.

  20. (mancilla2025majorantigenicdifferences pages 1-2): Marcos Mancilla, Adriana Ojeda, Yassef Yuivar, Maritza Grandón, Horst Grothusen, Marcela Oyarzún, Alejandro Bisquertt, Juan A. Ugalde, Francisco Fuentes, Pablo Ibarra, and Patricio Bustos. Major antigenic differences in aeromonas salmonicida isolates correlate with the emergence of a new strain causing furunculosis in chilean salmon farms. Frontiers in Cellular and Infection Microbiology, Feb 2025. URL: https://doi.org/10.3389/fcimb.2025.1508135, doi:10.3389/fcimb.2025.1508135. This article has 1 citations.

  21. (xiu2024evaluationofimmune pages 8-10): Yunji Xiu, Jingyuan Yi, Ruixin Feng, Jiaxue Song, Yunfei Pang, Peng Liu, and Shun Zhou. Evaluation of immune protection of a bivalent inactivated vaccine against aeromonas salmonicida and vibrio vulnificus in turbot. Fishes, 9:131, Apr 2024. URL: https://doi.org/10.3390/fishes9040131, doi:10.3390/fishes9040131. This article has 5 citations.

  22. (linz2023clinicalimpactof pages 16-17): Matthew S. Linz, Arun Mattappallil, Diana Finkel, and Dane Parker. Clinical impact of staphylococcus aureus skin and soft tissue infections. Antibiotics, 12:557, Mar 2023. URL: https://doi.org/10.3390/antibiotics12030557, doi:10.3390/antibiotics12030557. This article has 274 citations.

  23. (linz2023clinicalimpactof pages 2-3): Matthew S. Linz, Arun Mattappallil, Diana Finkel, and Dane Parker. Clinical impact of staphylococcus aureus skin and soft tissue infections. Antibiotics, 12:557, Mar 2023. URL: https://doi.org/10.3390/antibiotics12030557, doi:10.3390/antibiotics12030557. This article has 274 citations.

  24. (piewngam2024staphylococcusaureuscolonisation pages 9-11): Pipat Piewngam and Michael Otto. Staphylococcus aureus colonisation and strategies for decolonisation. The Lancet Microbe, 5:e606-e618, Jun 2024. URL: https://doi.org/10.1016/s2666-5247(24)00040-5, doi:10.1016/s2666-5247(24)00040-5. This article has 143 citations.

  25. (wojnarowski2024genomicanalysisof pages 12-13): Konrad Wojnarowski, Paulina Cholewińska, Peter Steinbauer, Tobias Lautwein, Wanvisa Hussein, Lisa-Marie Streb, and Dušan Palić. Genomic analysis of aeromonas salmonicida ssp. salmonicida isolates collected during multiple clinical outbreaks supports association with a single epidemiological unit. Pathogens, 13:908, Oct 2024. URL: https://doi.org/10.3390/pathogens13100908, doi:10.3390/pathogens13100908. This article has 4 citations.

  26. (wojnarowski2024genomicanalysisof pages 1-2): Konrad Wojnarowski, Paulina Cholewińska, Peter Steinbauer, Tobias Lautwein, Wanvisa Hussein, Lisa-Marie Streb, and Dušan Palić. Genomic analysis of aeromonas salmonicida ssp. salmonicida isolates collected during multiple clinical outbreaks supports association with a single epidemiological unit. Pathogens, 13:908, Oct 2024. URL: https://doi.org/10.3390/pathogens13100908, doi:10.3390/pathogens13100908. This article has 4 citations.

  27. (xiu2024evaluationofimmune pages 6-8): Yunji Xiu, Jingyuan Yi, Ruixin Feng, Jiaxue Song, Yunfei Pang, Peng Liu, and Shun Zhou. Evaluation of immune protection of a bivalent inactivated vaccine against aeromonas salmonicida and vibrio vulnificus in turbot. Fishes, 9:131, Apr 2024. URL: https://doi.org/10.3390/fishes9040131, doi:10.3390/fishes9040131. This article has 5 citations.

  28. (nowicka2019staphylococcusaureusand pages 2-4): Danuta Nowicka and Ewelina Grywalska. Staphylococcus aureus and host immunity in recurrent furunculosis. Dermatology, 235:295-305, Apr 2019. URL: https://doi.org/10.1159/000499184, doi:10.1159/000499184. This article has 64 citations and is from a peer-reviewed journal.

{ }

Source YAML

click to show 
name: Furunculosis
creation_date: "2026-02-18T23:25:35Z"
updated_date: "2026-02-19T14:59:54Z"
category: Infectious Disease
description: >
  Furunculosis is a recurrent deep follicular infection with localized abscess
  (boil) formation, usually caused by Staphylococcus aureus. The condition is
  closely linked to persistent colonization reservoirs and virulence factors,
  including Panton-Valentine leukocidin (PVL), that promote recurrence and
  severe suppurative disease.
synonyms:
- Recurrent furunculosis
- Recurrent boils
disease_term:
  preferred_term: furunculosis
  term:
    id: MONDO:0100595
    label: furunculosis
parents:
- Bacterial Infection
- Skin and soft tissue infection
infectious_agent:
- name: Staphylococcus aureus
  infectious_agent_term:
    preferred_term: Staphylococcus aureus
    term:
      id: NCBITaxon:1280
      label: Staphylococcus aureus
  description: >
    Staphylococcus aureus is the principal pathogen associated with recurrent
    furunculosis, with both methicillin-susceptible and methicillin-resistant
    lineages implicated in disease recurrence.
  evidence:
  - reference: PMID:22803835
    reference_title: "Recurrent furunculosis: a review of the literature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The majority of furuncles in the U.S.A. are caused by CA-MRSA, while elsewhere in the world they are caused by methicillin-sensitive S. aureus."
    explanation: Uses the abstract conclusion to support that S. aureus lineages are the principal causes of furunculosis.
  - reference: DOI:10.3390/antibiotics12030557
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The pathogenic bacterium Staphylococcus aureus is the most common pathogen isolated in skin-and-soft-tissue infections (SSTIs) in the United States."
    explanation: Furunculosis is a staphylococcal SSTI phenotype and this supports S. aureus as the dominant causative pathogen.
prevalence:
- population: Recurrent furunculosis cohorts
  percentage: "60%"
  notes: >
    Nasal carriage of S. aureus is commonly present in recurrent furunculosis.
  evidence:
  - reference: PMID:22803835
    reference_title: "Recurrent furunculosis: a review of the literature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Nasal carriage of S. aureus is the primary risk factor for recurrent furunculosis and occurs in 60% of individuals."
    explanation: Quantifies the high prevalence of S. aureus carriage among recurrent furunculosis patients.
- population: German village outbreak participants (2002-2004)
  percentage: "36%"
  notes: >
    In one community outbreak, over one-third of screened participants had nasal
    S. aureus colonization.
  evidence:
  - reference: PMID:17479931
    reference_title: "Successful termination of a furunculosis outbreak due to lukS-lukF-positive, methicillin-susceptible Staphylococcus aureus in a German village by stringent decolonization, 2002-2005."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Of 140 participants tested, 51 (36%) were found to be nasally colonized with S. aureus."
    explanation: Outbreak cohort data demonstrates substantial colonization prevalence in a furunculosis transmission setting.
transmission:
- name: Contact-associated transmission in community outbreaks
  description: >
    Person-to-person contact contributes to spread of epidemic furunculosis strains.
  evidence:
  - reference: PMID:17479931
    reference_title: "Successful termination of a furunculosis outbreak due to lukS-lukF-positive, methicillin-susceptible Staphylococcus aureus in a German village by stringent decolonization, 2002-2005."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Risk of furunculosis was associated with contact with case patients (relative risk, 6.8; 95% confidence interval, 3.2-14.3) and nasal colonization with a lukS-lukF-positive strain of S. aureus (relative risk, 3.6; 95% confidence interval, 2.3-5.9)."
    explanation: Demonstrates both direct contact and colonization-associated transmission risk in a community outbreak.
- name: Endogenous recurrence from asymptomatic colonization reservoirs
  description: >
    Recurrent episodes can arise from persistent asymptomatic colonization with
    S. aureus in nose/skin reservoirs.
  evidence:
  - reference: PMID:38518792
    reference_title: "Staphylococcus aureus colonisation and strategies for decolonisation."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Because S aureus infections commonly arise from asymptomatic colonisation, decolonisation is considered a key approach for their prevention."
    explanation: Supports the colonization-to-infection pathway driving recurrence.
pathophysiology:
- name: Colonization reservoir and follicular inoculation
  description: >
    Persistent S. aureus colonization of asymptomatic reservoirs predisposes to
    recurrent follicular inoculation and deep suppurative infection.
  cell_types:
  - preferred_term: keratinocyte
    term:
      id: CL:0000312
      label: keratinocyte
  - preferred_term: neutrophil
    term:
      id: CL:0000775
      label: neutrophil
  locations:
  - preferred_term: hair follicle
    term:
      id: UBERON:0002073
      label: hair follicle
  - preferred_term: hypodermis
    term:
      id: UBERON:0002072
      label: hypodermis
  biological_processes:
  - preferred_term: innate immune response
    term:
      id: GO:0045087
      label: innate immune response
  - preferred_term: neutrophil activation
    term:
      id: GO:0042119
      label: neutrophil activation
  downstream:
  - target: PVL-associated neutrophilic abscess injury
    description: >
      Toxin-producing strains are linked to more severe and recurrent follicular
      abscess phenotypes.
    evidence:
    - reference: PMID:22803835
      reference_title: "Recurrent furunculosis: a review of the literature."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "PVL is associated with follicular infections in general, having its strongest association with furunculosis and its recurrence."
      explanation: Connects follicular infection to PVL-driven recurrence in furunculosis.
  evidence:
  - reference: PMID:38518792
    reference_title: "Staphylococcus aureus colonisation and strategies for decolonisation."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Because S aureus infections commonly arise from asymptomatic colonisation, decolonisation is considered a key approach for their prevention."
    explanation: Supports asymptomatic colonization as the upstream reservoir for infection episodes.
  - reference: PMID:22803835
    reference_title: "Recurrent furunculosis: a review of the literature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Nasal carriage of S. aureus is the primary risk factor for recurrent furunculosis and occurs in 60% of individuals."
    explanation: Supports reservoir colonization as a central mechanism in recurrence.
- name: PVL-associated neutrophilic abscess injury
  description: >
    PVL-positive S. aureus strains are strongly associated with severe and
    recurrent furunculosis, consistent with toxin-amplified neutrophilic tissue
    injury and abscess formation.
  cell_types:
  - preferred_term: neutrophil
    term:
      id: CL:0000775
      label: neutrophil
  biological_processes:
  - preferred_term: neutrophil activation
    term:
      id: GO:0042119
      label: neutrophil activation
  downstream:
  - target: Recurrent cutaneous abscess formation
    description: >
      PVL-associated strains increase risk of recurrent and severe suppurative lesions.
    evidence:
    - reference: PMID:17479931
      reference_title: "Successful termination of a furunculosis outbreak due to lukS-lukF-positive, methicillin-susceptible Staphylococcus aureus in a German village by stringent decolonization, 2002-2005."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Strains harboring the lukS-lukF gene (which codes for Panton-Valentine leukocidin) are frequently associated with severe furunculosis."
      explanation: Directly links PVL genes to severe furunculosis.
  evidence:
  - reference: PMID:22803835
    reference_title: "Recurrent furunculosis: a review of the literature."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "PVL is associated with follicular infections in general, having its strongest association with furunculosis and its recurrence."
    explanation: Supports PVL as a key virulence driver of recurrent furunculosis.
  - reference: PMID:23973399
    reference_title: "Panton-Valentine leukocidin producing Staphylococcus aureus nasal carriage, in North-Lebanon."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The study revealed a high prevalence of luk-PV gene among methicillin-susceptible strains and a statistically significant correlation between the presence of this gene and presenting with an abscess."
    explanation: Correlates PVL gene carriage with abscess phenotype in human carriers.
- name: Adhesin-enriched follicular attachment
  description: >
    Chronic furunculosis isolates commonly harbor adhesin- and toxin-related
    virulence genes that support stable host-surface attachment and early lesion
    persistence.
  locations:
  - preferred_term: hair follicle
    term:
      id: UBERON:0002073
      label: hair follicle
  biological_processes:
  - preferred_term: cell adhesion involved in biofilm formation
    term:
      id: GO:0043708
      label: cell adhesion involved in biofilm formation
  downstream:
  - target: Single-species biofilm establishment in chronic furunculosis lesions
    description: >
      Adhesin-rich strains progress toward organized biofilm phenotypes that
      stabilize colonization.
    evidence:
    - reference: DOI:10.3390/pathogens14090923
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "In 90% of cases, S. aureus strains possessed the following virulence genes: clfA, clfB, spa, cna, eap, hlgA, hlgB, hlg, hld, bap, bbp, ebpS, fib, fnbA, fnbB, and pvl."
      explanation: The adhesin-rich virulence profile supports progression from attachment to biofilm-based persistence.
  evidence:
  - reference: DOI:10.3390/pathogens14090923
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "In 90% of cases, S. aureus strains possessed the following virulence genes: clfA, clfB, spa, cna, eap, hlgA, hlgB, hlg, hld, bap, bbp, ebpS, fib, fnbA, fnbB, and pvl."
    explanation: Demonstrates high prevalence of adhesion-associated virulence repertoire in chronic furunculosis isolates.
- name: Single-species biofilm establishment in chronic furunculosis lesions
  description: >
    S. aureus strains in chronic furunculosis show direct evidence of biofilm
    capacity, reinforcing lesion chronicity and tolerance to eradication.
  biological_processes:
  - preferred_term: biofilm formation
    term:
      id: GO:0042710
      label: biofilm formation
  - preferred_term: single-species biofilm formation
    term:
      id: GO:0044010
      label: single-species biofilm formation
  downstream:
  - target: MSSA-dominant persistent virulence reservoir
    description: >
      Biofilm-capable strains persist as a long-term reservoir and drive chronic
      recurrent episodes.
    evidence:
    - reference: DOI:10.3390/pathogens14090923
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "The predominance of MSSA in the etiology of chronic furunculosis and chronic osteomyelitis was observed."
      explanation: The predominance of chronic MSSA isolates is consistent with a persistent reservoir phenotype.
  evidence:
  - reference: DOI:10.3390/pathogens14090923
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Biofilm production was confirmed using the crystal violet method."
    explanation: Provides direct experimental support for biofilm-forming capability in the chronic furunculosis isolate set.
- name: MSSA-dominant persistent virulence reservoir
  description: >
    Chronic furunculosis is predominantly MSSA-driven, but those MSSA strains can
    retain virulence repertoires similar to MRSA, sustaining relapse risk.
  biological_processes:
  - preferred_term: single-species biofilm formation
    term:
      id: GO:0044010
      label: single-species biofilm formation
  downstream:
  - target: Early keratinocyte-neutrophil innate immune activation
    description: >
      Persistent high-virulence colonizing strains repeatedly trigger new rounds
      of local inflammatory activation.
    evidence:
    - reference: DOI:10.3390/antibiotics12030557
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "The immune response to S. aureus SSTIs involves initial responders such as keratinocytes and neutrophils, which are supported by dendritic cells and T-lymphocytes later during infection."
      explanation: Re-exposure to persistent strains is expected to reinitiate this early innate phase.
  evidence:
  - reference: DOI:10.3390/pathogens14090923
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "It has been demonstrated that MSSA possesses a similar set of virulence genes to MRSA and that MSSA is responsible for most cases of chronic osteomyelitis and furunculosis."
    explanation: Supports MSSA as a persistent, high-virulence reservoir in chronic furunculosis.
  - reference: DOI:10.3390/pathogens14090923
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The findings indicate that S. aureus possesses numerous virulence factors that play a key role in the processes of adhesion to and proliferation within host cells."
    explanation: Supports ongoing host persistence potential that can sustain chronic recurrence dynamics.
- name: Early keratinocyte-neutrophil innate immune activation
  description: >
    Initial host response to staphylococcal follicular infection is dominated by
    keratinocyte and neutrophil activation in the affected skin compartment.
  cell_types:
  - preferred_term: keratinocyte
    term:
      id: CL:0000312
      label: keratinocyte
  - preferred_term: neutrophil
    term:
      id: CL:0000775
      label: neutrophil
  biological_processes:
  - preferred_term: activation of innate immune response
    term:
      id: GO:0002218
      label: activation of innate immune response
  - preferred_term: innate immune response
    term:
      id: GO:0045087
      label: innate immune response
  downstream:
  - target: Dendritic-cell and T-cell adaptive immune phase
    description: >
      Early innate activation is followed by later adaptive immune cell support.
    evidence:
    - reference: DOI:10.3390/antibiotics12030557
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "The immune response to S. aureus SSTIs involves initial responders such as keratinocytes and neutrophils, which are supported by dendritic cells and T-lymphocytes later during infection."
      explanation: Directly supports temporal transition from early innate to later adaptive phases.
  evidence:
  - reference: DOI:10.3390/antibiotics12030557
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The immune response to S. aureus SSTIs involves initial responders such as keratinocytes and neutrophils, which are supported by dendritic cells and T-lymphocytes later during infection."
    explanation: Supports early innate phase dominated by keratinocytes and neutrophils.
- name: Dendritic-cell and T-cell adaptive immune phase
  description: >
    As lesions evolve, dendritic cells and T lymphocytes contribute to adaptive
    immune orchestration of the ongoing inflammatory response.
  cell_types:
  - preferred_term: dendritic cell
    term:
      id: CL:0000451
      label: dendritic cell
  - preferred_term: T cell
    term:
      id: CL:0000084
      label: T cell
  biological_processes:
  - preferred_term: adaptive immune response
    term:
      id: GO:0002250
      label: adaptive immune response
  - preferred_term: regulation of T cell differentiation
    term:
      id: GO:0045580
      label: regulation of T cell differentiation
  downstream:
  - target: Immune dysregulation sustaining recurrent furunculosis
    description: >
      In chronic disease contexts, persistent host-pathogen interaction can
      become maladaptive and perpetuate recurrence.
    evidence:
    - reference: DOI:10.1159/000499184
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Immunological and inflammatory processes of chronic furunculosis are based on the pathogenicity of <i>S. aureus</i> as well as innate and acquired immunity."
      explanation: Supports progression from active immune response to chronic immune-pathogenesis interactions.
  evidence:
  - reference: DOI:10.3390/antibiotics12030557
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The immune response to S. aureus SSTIs involves initial responders such as keratinocytes and neutrophils, which are supported by dendritic cells and T-lymphocytes later during infection."
    explanation: Supports the later adaptive phase involving dendritic cells and T cells.
- name: Immune dysregulation sustaining recurrent furunculosis
  description: >
    Chronic/recurrent furunculosis reflects persistent interaction between
    staphylococcal virulence and dysregulated innate-acquired immune processes.
  cell_types:
  - preferred_term: keratinocyte
    term:
      id: CL:0000312
      label: keratinocyte
  - preferred_term: dendritic cell
    term:
      id: CL:0000451
      label: dendritic cell
  - preferred_term: T cell
    term:
      id: CL:0000084
      label: T cell
  biological_processes:
  - preferred_term: innate immune response
    term:
      id: GO:0045087
      label: innate immune response
  - preferred_term: adaptive immune response
    term:
      id: GO:0002250
      label: adaptive immune response
  downstream:
  - target: Recurrent cutaneous abscess formation
    description: >
      Ongoing immune-pathogen interaction contributes to repeated disease relapses.
    evidence:
    - reference: PMID:17479931
      reference_title: "Successful termination of a furunculosis outbreak due to lukS-lukF-positive, methicillin-susceptible Staphylococcus aureus in a German village by stringent decolonization, 2002-2005."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "From January 1998 through December 2004, 42 cases and 59 relapses of furunculosis were identified by active case finding."
      explanation: Documents recurrent relapses as the downstream clinical consequence of chronic disease dynamics.
  evidence:
  - reference: DOI:10.1159/000499184
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Immunological and inflammatory processes of chronic furunculosis are based on the pathogenicity of <i>S. aureus</i> as well as innate and acquired immunity."
    explanation: Explicitly supports immune-pathogenesis coupling in recurrent furunculosis.
phenotypes:
- name: Furuncle
  category: Dermatologic
  description: >
    Deep follicular boil (localized abscess) that is the core lesion of furunculosis.
  phenotype_term:
    preferred_term: Furuncle
    term:
      id: HP:0020083
      label: Furuncle
  evidence:
  - reference: DOI:10.1159/000499184
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The most frequent <i>S. aureus</i> infections include impetigo, folliculitis, furuncles, furunculosis, abscesses, hidradenitis suppurativa, and mastitis."
    explanation: Furuncles are explicitly listed as frequent S. aureus clinical manifestations within recurrent furunculosis context.
- name: Recurrent cutaneous abscess formation
  category: Dermatologic
  phenotype_term:
    preferred_term: Recurrent cutaneous abscess formation
    term:
      id: HP:0100838
      label: Recurrent cutaneous abscess formation
  description: >
    Repeated episodes of painful cutaneous abscesses/boils driven by persistent
    S. aureus carriage and virulence factors.
  evidence:
  - reference: PMID:22803835
    reference_title: "Recurrent furunculosis: a review of the literature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "PVL is associated with follicular infections in general, having its strongest association with furunculosis and its recurrence."
    explanation: Supports recurrent abscess phenotype linked to PVL-positive furunculosis.
  - reference: PMID:17479931
    reference_title: "Successful termination of a furunculosis outbreak due to lukS-lukF-positive, methicillin-susceptible Staphylococcus aureus in a German village by stringent decolonization, 2002-2005."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "From January 1998 through December 2004, 42 cases and 59 relapses of furunculosis were identified by active case finding."
    explanation: Documents repeated relapses as a defining recurrent phenotype.
environmental:
- name: Close contact with affected individuals
  description: Community/household exposure to active cases increases furunculosis risk.
  effect: Increased risk of transmission and recurrence
  evidence:
  - reference: PMID:17479931
    reference_title: "Successful termination of a furunculosis outbreak due to lukS-lukF-positive, methicillin-susceptible Staphylococcus aureus in a German village by stringent decolonization, 2002-2005."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Risk of furunculosis was associated with contact with case patients (relative risk, 6.8; 95% confidence interval, 3.2-14.3) and nasal colonization with a lukS-lukF-positive strain of S. aureus (relative risk, 3.6; 95% confidence interval, 2.3-5.9)."
    explanation: Quantifies contact and colonization as epidemiologic risk factors.
- name: Persistent asymptomatic S. aureus carriage
  description: Ongoing colonization of nose/skin reservoirs promotes relapse after apparent resolution.
  effect: Predisposes to recurrent episodes
  evidence:
  - reference: PMID:38518792
    reference_title: "Staphylococcus aureus colonisation and strategies for decolonisation."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Because S aureus infections commonly arise from asymptomatic colonisation, decolonisation is considered a key approach for their prevention."
    explanation: Indicates asymptomatic carriage is a key upstream determinant of recurrent disease episodes.
treatments:
- name: Anti-staphylococcal antibiotic therapy
  description: >
    Oral anti-staphylococcal therapy is standard for many SSTIs, with parenteral
    escalation for severe presentations.
  treatment_term:
    preferred_term: pharmacotherapy
    term:
      id: MAXO:0000058
      label: pharmacotherapy
  evidence:
  - reference: DOI:10.3390/antibiotics12030557
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Treatment for S. aureus SSTIs is usually oral therapy, with parenteral therapy reserved for severe presentations; it ranges from cephalosporins and penicillin agents such as oxacillin, which is generally used for methicillin-sensitive S. aureus (MSSA), to vancomycin for methicillin-resistant S. aureus (MRSA)."
    explanation: Supports antibiotic treatment strategy and escalation by severity/resistance profile.
- name: Decolonization with intranasal mupirocin and antiseptic body cleansing
  description: >
    Combined decolonization protocols (intranasal mupirocin plus disinfecting
    washes/antiseptics) are used to interrupt recurrent transmission cycles.
  treatment_term:
    preferred_term: pharmacotherapy
    term:
      id: MAXO:0000058
      label: pharmacotherapy
  evidence:
  - reference: PMID:17479931
    reference_title: "Successful termination of a furunculosis outbreak due to lukS-lukF-positive, methicillin-susceptible Staphylococcus aureus in a German village by stringent decolonization, 2002-2005."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Nasally colonized persons, persons who had current furuncles or who had experienced relapsing furuncles since 2002, and their family members underwent stringent decolonization measures using mupirocin nasal ointment and disinfecting wash solution."
    explanation: Documents practical outbreak-control use of mupirocin plus antiseptic washing in recurrent furunculosis.
  - reference: PMID:38518792
    reference_title: "Staphylococcus aureus colonisation and strategies for decolonisation."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Current decolonisation procedures include antibiotic-based and antiseptic-based eradication of S aureus from the nose and skin."
    explanation: Supports decolonization as a prevention/treatment adjunct focused on reservoir eradication.
clinical_trials:
- name: NCT00513799
  phase: NOT_APPLICABLE
  status: COMPLETED
  description: >
    Randomized decolonization strategy study in community-associated S. aureus
    skin and soft tissue infections, including furunculosis, with follow-up for
    recurrence prevention.
  target_phenotypes:
  - preferred_term: Furuncle
    term:
      id: HP:0020083
      label: Furuncle
  - preferred_term: Recurrent cutaneous abscess formation
    term:
      id: HP:0100838
      label: Recurrent cutaneous abscess formation
  evidence:
  - reference: clinicaltrials:NCT00513799
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The purpose of this study is to determine the natural history of community-associated Staphylococcus aureus infections in both adult and pediatric patients by monitoring the rate of recurrent infections in those colonized with S. aureus."
    explanation: Directly addresses recurrence dynamics relevant to recurrent furunculosis.
  - reference: clinicaltrials:NCT00513799
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "In addition, this study will evaluate the efficiency of commonly prescribed decolonization measures in patients presenting with S. aureus skin and soft tissue infections."
    explanation: Supports clinical trial evaluation of decolonization strategies in furunculosis-relevant SSTIs.
- name: NCT01814371
  phase: NOT_APPLICABLE
  status: COMPLETED
  description: >
    Trial comparing individualized versus household decolonization approaches to
    prevent recurrent S. aureus skin infections in households with prior SSTI.
  target_phenotypes:
  - preferred_term: Furuncle
    term:
      id: HP:0020083
      label: Furuncle
  - preferred_term: Recurrent cutaneous abscess formation
    term:
      id: HP:0100838
      label: Recurrent cutaneous abscess formation
  evidence:
  - reference: clinicaltrials:NCT01814371
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The purpose of this research study is to compare the effectiveness of commonly used decolonization treatments (application of mupirocin antibiotic ointment to the nose and bleach baths) when performed by individuals with a history of skin and soft tissue infection (SSTI) in the prior year (individualized approach) in comparison to decolonization of all household members (household approach) in an attempt to prevent Staphylococcus aureus skin infections."
    explanation: Directly evaluates recurrence-prevention strategies in the furunculosis-relevant SSTI population.
- name: NCT00731783
  phase: NOT_APPLICABLE
  status: COMPLETED
  description: >
    Household-versus-individual S. aureus decolonization trial assessing
    eradication success and prevention of future staphylococcal skin infections.
  target_phenotypes:
  - preferred_term: Furuncle
    term:
      id: HP:0020083
      label: Furuncle
  - preferred_term: Recurrent cutaneous abscess formation
    term:
      id: HP:0100838
      label: Recurrent cutaneous abscess formation
  evidence:
  - reference: clinicaltrials:NCT00731783
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The purpose of this study is to determine whether measures to eliminate the Staph germ from the skin of the index patient (with a special ointment and soap) are more effective when performed by everyone in the household rather than the patient alone, and whether these methods are effective in preventing future Staph infections."
    explanation: Supports practical household-level decolonization interventions intended to prevent recurrent furunculosis-like infections.
diagnosis:
- name: Nasal swab screening for S. aureus colonization
  description: >
    Nasal swab surveillance identifies colonized individuals in recurrent
    furunculosis outbreaks.
  evidence:
  - reference: PMID:17479931
    reference_title: "Successful termination of a furunculosis outbreak due to lukS-lukF-positive, methicillin-susceptible Staphylococcus aureus in a German village by stringent decolonization, 2002-2005."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Nasal swab specimens were obtained from village residents."
    explanation: Confirms the use of nasal swab testing in outbreak diagnosis/management workflows.
- name: PCR detection of PVL and resistance-associated genes
  description: >
    Molecular testing can detect luk-PV and mecA in colonizing or infecting S. aureus strains.
  evidence:
  - reference: PMID:23973399
    reference_title: "Panton-Valentine leukocidin producing Staphylococcus aureus nasal carriage, in North-Lebanon."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The detection of 16S rRNA, mecA and luk-PV genes was performed by PCR and the risk factors were assessed with the statistical analysis of a questionnaire."
    explanation: Demonstrates PCR-based molecular characterization relevant to recurrence and virulence risk.
differential_diagnoses:
- name: Folliculitis
  disease_term:
    preferred_term: folliculitis
    term:
      id: MONDO:0006552
      label: folliculitis
  description: Superficial follicular inflammation that can precede but is usually less deep than furunculosis.
  distinguishing_features:
  - Furunculosis involves deeper suppurative abscess formation and recurrent boils.
  evidence:
  - reference: DOI:10.1159/000499184
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The most frequent <i>S. aureus</i> infections include impetigo, folliculitis, furuncles, furunculosis, abscesses, hidradenitis suppurativa, and mastitis."
    explanation: Supports folliculitis as a clinically overlapping S. aureus-related condition in the differential.
- name: Hidradenitis suppurativa
  disease_term:
    preferred_term: hidradenitis suppurativa
    term:
      id: MONDO:0006559
      label: hidradenitis suppurativa
  description: Chronic inflammatory nodules and sinus tracts in intertriginous areas can mimic recurrent boils.
  distinguishing_features:
  - Typical distribution in apocrine-rich intertriginous regions with sinus tract/scarring pattern.
  evidence:
  - reference: DOI:10.1159/000499184
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The most frequent <i>S. aureus</i> infections include impetigo, folliculitis, furuncles, furunculosis, abscesses, hidradenitis suppurativa, and mastitis."
    explanation: Supports hidradenitis suppurativa as an overlapping cutaneous condition considered alongside furunculosis.